Most Recent
New law would crack down on misleading broadband claims
A bill introduced this week seeks to crack down on misleading ads by broadband providers, a practice that recently landed broadband providers Telstra and Optus in hot water with Australia's consumer regulator.
ASIC bans life insurance adviser for 5 years
The Australian Securities and Investments Commission has banned a financial adviser for five years for failing to act in his clients' best interests, the second action taken by the corporate regulator through a project that uses data to target bad life insurance advisers.
Ex-Charter Financial adviser banned for fleecing elderly clients
A former financial adviser for Charter Financial Planning has been permanently barred from providing financial advice by Australia's corporate regulator after it found he deducted almost $67,000 in fees for advice he never gave.
Norton Rose dispute with ex-partner heads to mediation
A bitter court battle over the firing of a Norton Rose Fulbright employment partner in which the firm admitted it retroactively signed and dated a court document will soon head to mediation.
Banks pay $21.4M to consumers for bad financial advice
Australia's five biggest banks have paid out $21.4 million since the end of 2016 to consumers harmed by advice that violates financial services regulations, the Australian Securities and Investments Commission said Tuesday. 
ACCC to pursue big biz with bigger fines
The ACCC has set out its priorities for 2018, and bigger penalties for big business flouting competition laws is top of the agenda, the commission's chief said Tuesday.
Full court to hear Prysmian appeal next week
The Full Federal Court will hear arguments Monday from Prysmian Cavi E Sistemi that a $3.5 million fine handed down in a case brought by Australia’s competition regulator for alleged cartel conduct should be tossed out.
Start-up off hook for broken promises, rules NSW Appeals Court
A tech start-up that failed to deliver on a promise that investors would triple their money and was found liable for the entire investment has won a major reversal of the ruling on appeal.
GSK admits old Voltaren label was misleading
Drug giants GlaxoSmithKline and Novartis have conceded part of the ACCC's case that packaging on their Voltaren Osteo Gel breached the Australian Consumer Law, but said the label was changed almost a year ago.
ACCC cartel case to be conducted as eTrial
When trial kicks off in the ACCC's case against a company and individual allegedly involved in a roof sheeting cartel, there will be one thing missing that courtroom spectators have come to expect from complex commercial proceedings - reams of paper.